02 May 2013 - Sanofi incumple previsiones en 1er trim por pérdidas de patentes

Por Elena Berton PARIS (Reuters) - Sanofi reportó el jueves ganancias en el primer trimestre por debajo de lo previsto ya que los efectos de las pérdidas...

01 Mar 2013 - Research and Markets: 2013 Report on the $134 Billion US Pharmaceutical Preparation Manufacturing Industry and it's International Trade

Research and Markets (http://www.researchandmarkets.com/research/3x54pz/pharmaceutical) has announced the addition of Supplier Relations US, LLC's new...

28 Feb 2013 - Genzyme Recognizes International Rare Disease Day with Global Awareness Programs and Launch of Third Annual Patient Advocacy Leadership (PAL) Awards

Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced its support of International Rare Disease Day with a series of initiatives meant...

27 Feb 2013 - Bausch + Lomb designa a Robert Bertolini presidente y CFO

ROCHESTER, Nueva York, 26 de febrero de 2013 - /PRNewswire/ -- Bausch + Lomb, la compañía global dedicada a la salud visual, ha designado a Robert Bertolini...

27 Feb 2013 - Genzyme Receives Company Award from European Organisation for Rare Diseases (EURORDIS)

Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that it has received a Company Award from EURORDIS, the largest European patient...

26 Feb 2013 - Alnylam to Webcast Presentation at Cowen and Company 33rd Annual Health Care Conference

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the...

20 Feb 2013 - Research and Markets: Pompe Disease Global Clinical Trials Review, H1, 2013

Research and Markets (http://www.researchandmarkets.com/research/ggc8x2/pompe_disease) has announced the addition of GlobalData's new report "Pompe Disease...

15 Feb 2013 - Genzyme Announces Positive New Data from Two Phase 3 Studies for Oral Eliglustat Tartrate for Gaucher Disease

Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate,...

15 Feb 2013 - Research and Markets: Stem Cell Research - Global Business Strategic Report

Research and Markets (http://www.researchandmarkets.com/research/hvlmt6/stem_cell) has announced the addition of the "Stem Cell Research - Global Business...

07 Feb 2013 - Research and Markets: European Wound and Tissue Management Markets 2012-2018 - Executive Summary

Research and Markets (http://www.researchandmarkets.com/research/mfn8pl/european_wound) has announced the addition of the "European Wound and Tissue Management...

07 Feb 2013 - Ganancia de Sanofi cae 24 pct en 4to trim, crecimiento volverá en 2do semestre

PARIS (Reuters) - Sanofi reportó el jueves una disminución de un 24 por ciento en sus ganancias del cuarto trimestre y pronosticó que el crecimiento se...

Cotizaciones

 De Hoy

 De los Últimos Días

 Del Año